<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Essays Res</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Essays Res</journal-id><journal-id journal-id-type="publisher-id">AER</journal-id><journal-title-group><journal-title>Anesthesia, Essays and Researches</journal-title></journal-title-group><issn pub-type="ppub">0259-1162</issn><issn pub-type="epub">2229-7685</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25886102</article-id><article-id pub-id-type="pmc">4173598</article-id><article-id pub-id-type="publisher-id">AER-8-41</article-id><article-id pub-id-type="doi">10.4103/0259-1162.128907</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A comparative study of pre-operative oral clonidine and pregabalin on post-operative analgesia after spinal anesthesia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Prasad</surname><given-names>Anu</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Bhattacharyya</surname><given-names>Susmita</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Biswas</surname><given-names>Atanu</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Saha</surname><given-names>Mrityunjaya</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Mondal</surname><given-names>Sudeshna</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Saha</surname><given-names>Dona</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Anaesthesiology, Burdwan Medical College and Hospitals, West Bengal University of Health Sciences, Burdwan, West Bengal, India</aff><author-notes><corresp id="cor1">
Corresponding author: Dr. Susmita Bhattacharyya, Flat No. C3, Block E, Meena Residency, Teghoria, Kolkata - 700 059, West Bengal, India. E-mail: <email xlink:href="agamoni_bhat@rediffmail.com">agamoni_bhat@rediffmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Apr</season><year>2014</year></pub-date><volume>8</volume><issue>1</issue><fpage>41</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright: &#x000a9; Anesthesia: Essays and Researches</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objectives:</title><p>Pregabalin and clonidine have anti-nociceptive properties. This study assesses their efficacy in prolonging the analgesic effect of spinal anesthesia and post-operative analgesic requirement in patients undergoing vaginal hysterectomy.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>A total of 90 females in the age group of 30-60 years were randomly allocated in to three groups of 30 each, to receive either oral clonidine (150 &#x003bc;g) or oral pregabalin (150 mg) or oral multivitamin as placebo 1.5 h before spinal anesthesia with 3ml (15 mg) of 0.5% hyperbaric bupivacaine. Intensity of pain was measured on a visual analog scale (VAS) at the end of operation (0 h) then at 1,2,4,6,12 and 24 h thereafter. Diclofenac sodium intramuscularly 1 mg/kg was provided when the VASscore was &#x0003e;4 in the study period. Sedation was defined by Ramsay sedation scale at 0,6,12 and 24 h. Side-effects such as nausea and vomiting, respiratory depression and dryness of mouth were noted.</p></sec><sec id="st3"><title>Results:</title><p>The VAS scores were significantly less in the pregabalin group compared with the clonidine group at 6,12 and 24 h post-operatively with a <italic>P</italic> &#x0003c; 0.0001. More sedation was seen in the clonidine group than in the pregabalin group (<italic>P</italic> &#x0003c; 0.05). Analgesic consumption and VAS scores were lower in clonidine and pregabalin group compared with the placebo group (<italic>P</italic> &#x0003c; 0.05).</p></sec><sec id="st4"><title>Conclusion:</title><p>Oral pregabalin (150 mg) prolongs the post-operative pain relief after spinal anesthesia but produces less sedation compared with oral clonidine (150 &#x003bc;g).</p></sec></abstract><kwd-group><kwd>Clonidine</kwd><kwd>post-operative analgesia</kwd><kwd>pregabalin</kwd><kwd>Ramsay sedation scale</kwd><kwd>vaginal hysterectomy</kwd><kwd>visual analog scale score</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Pain is derived from the word <italic>poena</italic> meaning punishment. Pain is an unpleasant sensation that originates from ongoing and impending tissue damage. Acute pain accompanies almost all surgical procedures. Adequate pain relief provides a quick return to normal physiological function and prevents the development of chronic pain. Traditional analgesia in the post-operative period is based on opioids, non-steroidal anti-inflammatory drugs (NSAIDS) and regional techniques. Administration of high doses of opioids during the post-operative period can result in higher incidence of complications such as respiratory depression, sedation, vomiting, constipation, pruritus, immune dysfunction and urinary retention.[<xref rid="ref1" ref-type="bibr">1</xref>] NSAIDS may lead to gastrointestinalbleeding, renal toxicity and thromboembolic complications. Regional analgesia techniques require additional intervention and have the potential risk of complications such as hypotension, bradycardia and toxicity of the administered drug. Hence, the search for an ideal drug continues. A drug, which has anxiolytic property without the adverse effects of traditional analgesics mentioned, may be an attractive choice for post-operative analgesia.</p><p>Pregabalin is a lipophilic gamma-amino-butyric-acid (GABA) analog with anti-convulsant, anxiolyitc and sleep modulating properties. Pregabalin was shown to be effective in neuropathic pain, incisional injury and inflammatory injury.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] Clonidine is a selective partial alpha<sub>2</sub> receptor agonist, which has sedative and anti-nociceptive properties. The aim of our study was to compare the duration of post-operative analgesia with oral pregabalin and clonidine after spinal anesthesia and the number of doses of diclofenac sodium injection required during the first 24 h after surgery among the study groups. We also assessed the side effects of the study drugs such as respiratory depression, nausea, vomiting and dryness of mouth.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><p>This is randomized, double-blind, controlled study carried out with the permission of the Institutional Ethics&#x02019;Committee and after obtaining written informed consent of the patients. A total of 90 female patients in the age group 30 to 60 years of American Society of Anesthesiologists (ASA)-physical status I and II undergoing elective vaginal hysterectomy were selected for the study. The group size of 30 was determined by power analysis based on standard deviation (SD) data from previously published reports.[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] Patients having a body mass index &#x0003e; 30 kg/m<sup>2</sup>, suffering from central nervous system disorders, having chronic pain conditions or had taken analgesics in the last 48 h were excluded from the study. Those having contraindications of spinal anesthesia were exempted from the study.</p><p>All patients were clinically evaluated pre-operatively and relevant laboratory investigations were obtained. The selected patients were randomly allocated in to three groups of 30 each based on a computer generated randomization table. The anesthesiologists who provided the drugs and those who recorded the data were all blinded to the group identities. Each group was given the study drug orally 1.5 h before the procedure in the following manner: Group A: Received150 &#x003bc;g of oral clonidine; Group B: received 150 mg of oral pregabalin; Group C: Received oral multivitamin [<xref ref-type="fig" rid="F1">Figure 1</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Method of the study</p></caption><graphic xlink:href="AER-8-41-g001"/></fig><p>In the operation theater, baseline non-invasive blood pressure, electrocardiogram, pulse rate (PR) and oxygen saturation (SpO<sub>2</sub>%) were monitored. In the operating room, intravenous access was done with an 18 G cannula and Ringers&#x02019;lactate infusion (500 ml) was infused at the rate of 10 ml/kg over 30 min and there after at the rate of 5 ml/kg/h through the rest of the intra-operative period. Spinal anesthesia was given in the sitting position through midline approach at L<sub>3</sub>-L<sub>4</sub> intervertebral space using 26 G spinal needle and 3 ml of 0.5% hyperbaric bupivacaine was given. Patients were positioned in the supine position after intrathecal injection. Onset of sensory block was assessed bilaterally by loss of pinprick sensation with a short hypodermic needle. After achieving the sensory block up to T<sub>10</sub> dermatome level and motor block of 3 on Bromage scale [<xref ref-type="table" rid="T1">Table 1</xref>] we allowed the surgery to begin.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Bromage scale</p></caption><graphic xlink:href="AER-8-41-g002"/></table-wrap><p>Intra-operative hemodynamic monitoring was done. When the mean arterial pressure (MAP) fell below 20% of the baseline value, phenylephrine 1 &#x003bc;g/kg was given intravenously and repeated after 5 min if required. If PR was &#x0003c;60 beats/min atropine 0.6 mg was given. No sedatives or analgesics were given during the intra-operative period. After operation patients were shifted to the post-anesthesia care unit. In the post-operative period intensity of pain was measured on a 10-point visual analog scale (VAS) at end of operation [0 hr] then 1, 2, 4, 6, 12 and 24 h after the operation.</p><p>Those patients who had a VAS score of &#x0003e;4 were given injection diclofenac sodium 1 mg/kg intramuscularly as a rescue analgesic. The number of doses of analgesic given in the first 24 h was documented. Sedation was scored on Ramsay sedation scale (RSS) at 0, 6, 12 and 24 h after operation. We also noted other side-effects such as respiratory depression, nausea and vomiting and dryness of mouth. Any incidence of respiratorydepression (respiratory rate &#x0003c;8 breaths/min or SpO<sub>2</sub> &#x0003c;90% without supplementation) was to be corrected with supplemental oxygen through facemask.</p></sec><sec id="sec1-3"><title>RSS</title><p>Statistical analysis was performed by entering data in Microsoft Excel database and subsequently analyzed by standard statistical software like SPSS (StatisticalProductfortheSocialSciences version 19; manufacturer SPSS Inc. 223 South Wacker Drive, 11<sup>th</sup> floor, Chicago, IL 60606-6412, U.S.A.). Results are expressed in mean &#x000b1; SD. Numerical variables were compared between the groups using unpaired <italic>t</italic>-test. The significance of change in VAS score from first to final assessment was evaluated by repeated measures ANOVA. All analysis was two-tailed and <italic>P</italic> &#x0003c; 0.05 was considered to be statistically significant and a <italic>P</italic> &#x0003c; 0.0001 as highly significant.</p></sec><sec sec-type="results" id="sec1-4"><title>RESULTS</title><p>A total of 90 patients who underwent vaginal hysterectomy under spinal anesthesia were included in the study and were randomly allocated to three groups of 30 each. The ASA physical status was similar in all the three groups. The demographic profile of all the three groups was comparable with respect to age, weight and height, duration of surgery [<xref ref-type="table" rid="T2">Table 2</xref>]. Baseline PR, MAP and SpO<sub>2</sub> are comparable in all three groups. There were no statistically significant changes in these parameters in subsequent recordings [Figures <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F3">3</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The demographic profile and duration of surgery</p></caption><graphic xlink:href="AER-8-41-g003"/></table-wrap><fig id="F2" position="float"><label>Figure 2</label><caption><p>Comparison of mean arterial pressure</p></caption><graphic xlink:href="AER-8-41-g004"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Comparison of the pulse rate</p></caption><graphic xlink:href="AER-8-41-g005"/></fig><p>The difference in intensity of pain scores on a VAS scale between the study Group A (0.52 &#x000b1; 0.51, 2.58 &#x000b1; 0.56, 5.35 &#x000b1; 0.95, 4.51 &#x000b1; 0.99, 4.82 &#x000b1; 0.51, 5.61 &#x000b1; 0.80, 4.55 &#x000b1; 1.03) or Group B (0.39 &#x000b1; 0.56, 2.55 &#x000b1; 0.85, 4.94 &#x000b1; 1.34, 4.10 &#x000b1; 0.87, 4.14 &#x000b1; 0.85, 3.52 &#x000b1; 0.89, 3.58 &#x000b1; 0.96) compared to Group C (0.77 &#x000b1; 0.72, 4.87 &#x000b1; 1.09, 6.48 &#x000b1; 0.63, 4.48 &#x000b1; 0.81, 5.29 &#x000b1; 0.78, 6.58 &#x000b1; 1.12, 6.00 &#x000b1; 1.18) at 0, 1, 2, 4, 6, 12 and 24 h of post-operative period respectively was highly significant statistically with a <italic>P</italic> &#x0003c; 0.0001. The duration of analgesia was significantly more in the Group B compared to Group A after 6 h of post-operative period <italic>P</italic> &#x0003c; 0.05 [<xref ref-type="table" rid="T3">Table 3</xref>, <xref ref-type="fig" rid="F4">Figure 4</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of post-operative visual analog score</p></caption><graphic xlink:href="AER-8-41-g006"/></table-wrap><fig id="F4" position="float"><label>Figure 4</label><caption><p>Comparison of the visual analog score scores of the clonidine, pregabalin and the placebo group</p></caption><graphic xlink:href="AER-8-41-g007"/></fig><p>Incidence of sedation was higher in the Group A just at the end of operation with six patients (20%) having a RSS score of 4 compared to only one patient (3%) in the Group B (<italic>P</italic> &#x0003c; 0.05). During the rest of the observation period the patients in both the groups had a RSS of less than 3. In the placebo group, all the patient were observed to have a RSS score of 2 or 1 throughout the period of observation [Figures <xref ref-type="fig" rid="F5">5</xref> and <xref ref-type="fig" rid="F6">6</xref>].</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Ramsay sedation scale score of the clonidine group</p></caption><graphic xlink:href="AER-8-41-g008"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><p>Ramsay sedation scale score of the pregablin group</p></caption><graphic xlink:href="AER-8-41-g009"/></fig><p>Time to first demand of a rescue analgesic was more with clonidine (238.41 &#x000b1; 7.32 min) and pregabalin (252.14 &#x000b1; 5.02 min) than with placebo (178.24 &#x000b1; 7.43 min) [<xref ref-type="table" rid="T4">Table 4</xref>].</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Mean duration of spinal analgesia</p></caption><graphic xlink:href="AER-8-41-g010"/></table-wrap><p>In the Group C 80% patients required three doses each of 1 mg/kg of intramuscular diclofenac sodium as rescue analgesic whereas majority in the Group B (70%) and the Group A (57%) sufficed with only a single dose [<xref ref-type="table" rid="T5">Table 5</xref>, <xref ref-type="fig" rid="F7">Figure 7</xref>].</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Comparison of doses of intramuscular diclofenac sodium (1 mg/kg)</p></caption><graphic xlink:href="AER-8-41-g011"/></table-wrap><fig id="F7" position="float"><label>Figure 7</label><caption><p>Diclofenac sodium requirement</p></caption><graphic xlink:href="AER-8-41-g012"/></fig><p>There was no incidence of respiratory depression or dry mouth in the study groups A and B The episodes of post-operative nausea and vomiting were comparable in all the three groups and not statistically significant [<xref ref-type="table" rid="T6">Table 6</xref>].</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Side-effects of study drugs</p></caption><graphic xlink:href="AER-8-41-g013"/></table-wrap></sec><sec sec-type="discussion" id="sec1-5"><title>DISCUSSION</title><p>Pain is the most common complaint in the post-operative period. Pain signals start a cascade of alterations in the somatosensory systems, which increases the response to subsequent stimuli and thus amplify pain.[<xref rid="ref8" ref-type="bibr">8</xref>]</p><p>Clonidine is an &#x003b1;<sub>2</sub> adrenergic agonist that produces dose dependent analgesia at spinal and supraspinal sites. Oral clonidine is almost completely absorbed and peak plasma concentration is reached after 1-3 h of administration. It is highly lipid soluble, crosses the blood brain barrier easily. Clonidine inhibits neurotransmission in both A-delta and C fibers and potentiates inhibitory effect of the local anesthetic on the C-fiber activity. Pregabalin is a GABA analog that binds to the &#x003b1;<sub>2</sub>-d subunit of the presynaptic voltage-dependent calcium channels that are widely distributed throughout the central and peripheral nervous systems.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>] It reduces the release of several neurotransmitters such as glutamate, norepinephrine, serotonin, dopamine and substance P.[<xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref>] Pregabalin is inactive at GABA<sub>A</sub> and GABA<sub>B</sub> receptors.[<xref rid="ref19" ref-type="bibr">19</xref>] Its elimination half-life is 5.5-6.7 h independent of dose and repeated administration. Side-effects of pregabalin include dizziness, somnolence, dry mouth etc.</p><p>We selected the dose of oral clonidine to be 150 mcg as the incidence of bradycardia and hypotension is more with higher doses during spinal anesthesia.[<xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref>] A test dose of 150 mg of pregabalin was based on the studies where such a dose produced no acute hemodynamic alterations as well as sedation.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref22" ref-type="bibr">22</xref>] In our study, 150 mcg oral clonidine and pregablin 150 mg was given 1.5 h before spinal anesthesia, which prolonged the duration of analgesia and maintained the VAS scores at 0, 1, 2, 4, 6, 12 and 24 h in the lower range in comparison with the placebo group (<italic>P</italic> &#x0003c; 0.05). Rescue analgesic doses required was less in the Group A and Group B than in the Group C (<italic>P</italic> &#x0003c; 0.05). RSS score was more in Group A and B than Group C. There were no significant hemodynamic changes in all the groups [Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>].</p><p>Montazeri and Ghobadian found out that with oral clonidine in spinal anesthesia, the mean duration of sensory and motor blockade was increased.[<xref rid="ref23" ref-type="bibr">23</xref>] Liu <italic>et al</italic>., Ota <italic>et al</italic>. and Singh <italic>et al</italic>. observed that oral clonidine 150-200 mcg given 1-1.5 h before spinal anesthesia caused significant prolongation of sensory analgesia.[<xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref24" ref-type="bibr">24</xref>] Partahusniutojo showed that the mean duration of sensory analgesia was significantly prolonged with 150 mcg oral clonidine in spinal anesthesia.[<xref rid="ref25" ref-type="bibr">25</xref>] Joleka <italic>et al</italic>. found that there was a decreased post-operative requirement of analgesics in pregabalin (300 mg) group compared with those in the diazepam (10 mg) group with increased incidence of dizziness and blurred vision in the pregabalin group.[<xref rid="ref26" ref-type="bibr">26</xref>] Tiippana <italic>et al</italic>. did a meta-analysis of the Medline and Cochrane Central Register of Controlled Trials (CENTRAL) databases regarding perioperative administration of gabapentinoids and concluded that they effectively reduced post-operative pain, opioid consumption and their adverse effects.[<xref rid="ref27" ref-type="bibr">27</xref>]</p><p>In our study, mean duration of sensory analgesia in GroupA (238.41 &#x000b1; 7.32 min) and in Group B was (252.14 &#x000b1; 5.02 min), which was statistically significant (<italic>P</italic> &#x0003c; 0.05). The VAS score at rest was significantly different between Group A and Group B during the observations made at 0, 1 h and thereafter most of the patients demanded a rescue analgesic. After giving the rescue analgesic the VAS score was significantly lower in Group B (<italic>P</italic> &#x0003c; 0.001) than Group A beyond 6 h of observation in the post-operative period. It was seen that 57% and 70% of patients in the Group A and Group B respectively required only a single dose of diclofenac sodium whereas 80% patients in the Group C had to be administered three doses of diclofenac in the 24 h study period. The difference was statistically significant and supported the role of pain prevention in surgery with clonidine and pregabalin. Ghafari <italic>et al</italic>., did a comparative study of oral clonidine (100 mcg) and gabapentin (300 mg) given pre-operatively in 99 women undergoing abdominal hysterectomy. They found out that both gabapentin and clonidine group had a post-operative VAS score and total morphine consumption less than that of the placebo group (<italic>P</italic> &#x0003c; 0.05). Gabapentin group had a better pain score than clonidine group.[<xref rid="ref6" ref-type="bibr">6</xref>] Kohli <italic>et al</italic>. conducted a randomized trial on patients undergoing hysterectomy under spinal anesthesia and concluded that oral pregabalin provides immediate post-operative analgesia by prolonging the neuraxial block and reduces the frequency of administration of parenteral analgesics.[<xref rid="ref22" ref-type="bibr">22</xref>] Mathiesen <italic>et al</italic>. showed that there was decreased 24 h analgesic consumption in patients undergoing total hip arthroplasty who had received pregabalin with paracetamol compared to those who had received only paracetamol.[<xref rid="ref28" ref-type="bibr">28</xref>] Ittichaikulthol <italic>et al</italic>. found out that there was decreased verbal numerical rating scale pain score and decreased 24 h morphine consumption in pregabalin (300 mg) group in comparison with lorazepam (0.5 mg) given 1 h before abdominal hysterectomy.[<xref rid="ref29" ref-type="bibr">29</xref>] All these studies suggest that both clonidine and pregabalin prolonged the duration of sensory analgesia after spinal blockade and reduce the analgesic requirement on the post-operative period. Their finding corroborates with our study.</p><p>Both clonidine and pregabalin have sedative properties. 6 (20%) patients of Group A had a RSS score of 4 at 0 h, but were arousable by gentle tactile stimulation. In the Group B only 1 (3%) of the patients had a RSS score of 4 at 0 h of observation, but they remained awake, calm and cooperative. This suggested that clonidine produces more sedation than pregabalin after oral administration. Other studies also suggest sedation with oral clonidine 150 mcg and pregabalin 150 mg.[<xref rid="ref30" ref-type="bibr">30</xref><xref rid="ref31" ref-type="bibr">31</xref>] Incidence of nausea and vomiting, dry mouth was not significantly different among the groups.</p><p>We conclude that oral pregabalin in the dose of 150 mg prolonged the duration of spinal analgesia and provided better post-operative analgesia, less analgesic requirement and less sedation than oral clonidine in the dose of 150 &#x003bc;g in patients receiving spinal anesthesia.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolin</surname><given-names>SJ</given-names></name><name><surname>Cashman</surname><given-names>JN</given-names></name></person-group><article-title>Tolerability of acute postoperative pain management: Nausea, vomiting, sedation, pruritus, and urinary retention. Evidence from published data</article-title><source>Br J Anaesth</source><year>2005</year><volume>95</volume><fpage>584</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">16169893</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nozaki-Taguchi</surname><given-names>N</given-names></name><name><surname>Chaplan</surname><given-names>SR</given-names></name><name><surname>Higuera</surname><given-names>ES</given-names></name><name><surname>Ajakwe</surname><given-names>RC</given-names></name><name><surname>Yaksh</surname><given-names>TL</given-names></name></person-group><article-title>Vincristine-induced allodynia in the rat</article-title><source>Pain</source><year>2001</year><volume>93</volume><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">11406340</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>MJ</given-names></name><name><surname>Holloman</surname><given-names>EF</given-names></name><name><surname>McCleary</surname><given-names>S</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>L</given-names></name></person-group><article-title>Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain</article-title><source>J PharmacolExpTher</source><year>1997</year><volume>282</volume><fpage>1242</fpage><lpage>6</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>MJ</given-names></name><name><surname>Oles</surname><given-names>RJ</given-names></name><name><surname>Lewis</surname><given-names>AS</given-names></name><name><surname>McCleary</surname><given-names>S</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>L</given-names></name></person-group><article-title>Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents</article-title><source>Br J Pharmacol</source><year>1997</year><volume>121</volume><fpage>1513</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">9283683</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houghton</surname><given-names>AK</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Westlund</surname><given-names>KN</given-names></name></person-group><article-title>S-(+)-3-isobutylgaba and its stereoisomer reduces the amount of inflammation and hyperalgesia in an acute arthritis model in the rat</article-title><source>J PharmacolExpTher</source><year>1998</year><volume>285</volume><fpage>533</fpage><lpage>8</lpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghafari</surname><given-names>MH</given-names></name><name><surname>Akrami</surname><given-names>M</given-names></name><name><surname>Nouralishahi</surname><given-names>B</given-names></name><name><surname>Sadegh</surname><given-names>A</given-names></name></person-group><article-title>Preoperative gabapentin or clonidine decreases postoperative pain and morphine consumption after abdominal hysterectomy</article-title><source>Res J BiolSci</source><year>2009</year><volume>4</volume><fpage>458</fpage><lpage>63</lpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rastogi</surname><given-names>B</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name><name><surname>Gupta</surname><given-names>PK</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Chauhan</surname><given-names>H</given-names></name></person-group><article-title>Oral pregabalin premedication for attenuation of haemodynamicpressor response of airway instrumentation during general anaesthesia: A dose response study</article-title><source>Indian J Anaesth</source><year>2012</year><volume>56</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">22529420</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Salter</surname><given-names>MW</given-names></name></person-group><article-title>Neuronal plasticity: Increasing the gain in pain</article-title><source>Science</source><year>2000</year><volume>288</volume><fpage>1765</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10846153</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arikkath</surname><given-names>J</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name></person-group><article-title>Auxiliary subunits: Essential components of the voltage-gated calcium channel complex</article-title><source>CurrOpinNeurobiol</source><year>2003</year><volume>13</volume><fpage>298</fpage><lpage>307</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bian</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Offord</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>MD</given-names></name><name><surname>McCormick</surname><given-names>J</given-names></name><name><surname>Taylor</surname><given-names>CP</given-names></name><etal/></person-group><article-title>Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: An <italic>ex vivo</italic>autoradiographic study in alpha2-delta type 1 genetically modified mice</article-title><source>Brain Res</source><year>2006</year><volume>1075</volume><fpage>68</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">16460711</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belliotti</surname><given-names>TR</given-names></name><name><surname>Capiris</surname><given-names>T</given-names></name><name><surname>Ekhato</surname><given-names>IV</given-names></name><name><surname>Kinsora</surname><given-names>JJ</given-names></name><name><surname>Field</surname><given-names>MJ</given-names></name><name><surname>Heffner</surname><given-names>TG</given-names></name><etal/></person-group><article-title>Structure-activity relationships of pregabalin and analogues that target the alpha (2)-delta protein</article-title><source>J Med Chem</source><year>2005</year><volume>48</volume><fpage>2294</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">15801823</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazulla</surname><given-names>J</given-names></name><name><surname>Tintor&#x000e9;</surname><given-names>MA</given-names></name></person-group><article-title>The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: Gabapentin and pregabalin may be of therapeutic benefit</article-title><source>Med Hypotheses</source><year>2007</year><volume>68</volume><fpage>131</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16899342</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dooley</surname><given-names>DJ</given-names></name><name><surname>Donovan</surname><given-names>CM</given-names></name><name><surname>Pugsley</surname><given-names>TA</given-names></name></person-group><article-title>Stimulus-dependent modulation of [(3) H] norepinephrine release from rat neocortical slices by gabapentin and pregabalin</article-title><source>J PharmacolExpTher</source><year>2000</year><volume>295</volume><fpage>1086</fpage><lpage>93</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dooley</surname><given-names>DJ</given-names></name><name><surname>Mieske</surname><given-names>CA</given-names></name><name><surname>Borosky</surname><given-names>SA</given-names></name></person-group><article-title>Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin</article-title><source>NeurosciLett</source><year>2000</year><volume>280</volume><fpage>107</fpage><lpage>10</lpage></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>K</given-names></name><name><surname>Dooley</surname><given-names>DJ</given-names></name><name><surname>Meder</surname><given-names>WP</given-names></name><name><surname>Suman-Chauhan</surname><given-names>N</given-names></name><name><surname>Duffy</surname><given-names>S</given-names></name><name><surname>Clusmann</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inhibition of neuronal Ca (2+) influx by gabapentin and pregabalin in the human neocortex</article-title><source>Neuropharmacology</source><year>2002</year><volume>42</volume><fpage>229</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">11804619</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Errante</surname><given-names>LD</given-names></name><name><surname>Petroff</surname><given-names>OA</given-names></name></person-group><article-title>Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations</article-title><source>Seizure</source><year>2003</year><volume>12</volume><fpage>300</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12810343</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>MO</given-names></name><name><surname>Woodhall</surname><given-names>GL</given-names></name><name><surname>Thompson</surname><given-names>SE</given-names></name><name><surname>Dooley</surname><given-names>DJ</given-names></name><name><surname>Jones</surname><given-names>RS</given-names></name></person-group><article-title>Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses <italic>in vitro</italic></article-title><source>Eur J Neurosci</source><year>2004</year><volume>20</volume><fpage>1566</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">15355323</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micheva</surname><given-names>KD</given-names></name><name><surname>Taylor</surname><given-names>CP</given-names></name><name><surname>Smith</surname><given-names>SJ</given-names></name></person-group><article-title>Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons</article-title><source>MolPharmacol</source><year>2006</year><volume>70</volume><fpage>467</fpage><lpage>76</lpage></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanneau</surname><given-names>C</given-names></name><name><surname>Green</surname><given-names>A</given-names></name><name><surname>Hirst</surname><given-names>WD</given-names></name><name><surname>Wise</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>JT</given-names></name><name><surname>Donnier</surname><given-names>E</given-names></name><etal/></person-group><article-title>Gabapentin is not a GABAB receptor agonist</article-title><source>Neuropharmacology</source><year>2001</year><volume>41</volume><fpage>965</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">11747901</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Chiu</surname><given-names>AA</given-names></name><name><surname>Neal</surname><given-names>JM</given-names></name><name><surname>Carpenter</surname><given-names>RL</given-names></name><name><surname>Bainton</surname><given-names>BG</given-names></name><name><surname>Gerancher</surname><given-names>JC</given-names></name></person-group><article-title>Oral clonidine prolongs lidocaine spinal anesthesia in human volunteers</article-title><source>Anesthesiology</source><year>1995</year><volume>82</volume><fpage>1353</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7793648</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>K</given-names></name><name><surname>Namiki</surname><given-names>A</given-names></name><name><surname>Iwasaki</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>I</given-names></name></person-group><article-title>Dosing interval for prolongation of tetracaine spinal anesthesia by oral clonidine in humans</article-title><source>AnesthAnalg</source><year>1994</year><volume>79</volume><fpage>1117</fpage><lpage>20</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohli</surname><given-names>M</given-names></name><name><surname>Murali</surname><given-names>T</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>P</given-names></name><name><surname>Bogra</surname><given-names>J</given-names></name></person-group><article-title>Optimization of subarachanoid block by oral pregabalin for hysterectomy</article-title><source>J AnaesthesiolClinPharmacol</source><year>2011</year><volume>27</volume><fpage>101</fpage><lpage>5</lpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montazeri</surname><given-names>K</given-names></name><name><surname>Ghobadian</surname><given-names>A</given-names></name></person-group><article-title>Oral clonidine as a premedication in spinal anesthesia: Effects on the duration of block and hemodynamic status a randomised double blind clinical trial</article-title><source>Journal of Research in Medical Sciences</source><year>2002</year><volume>7</volume><comment>No 4</comment></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Gaines</surname><given-names>GY</given-names></name><name><surname>White</surname><given-names>PF</given-names></name></person-group><article-title>Effect of oral clonidine and intrathecal fentanyl on tetracaine spinal block</article-title><source>AnesthAnalg</source><year>1994</year><volume>79</volume><fpage>1113</fpage><lpage>6</lpage></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Partahusniutojo</surname><given-names>P</given-names></name></person-group><article-title>The effect of oral clonidine premedication on the duration of hyperbaric tetracaine spinal anesthesia</article-title><source>Philipp J Anesthesiol</source><year>1999</year><volume>11</volume><fpage>32</fpage><lpage>9</lpage></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jokela</surname><given-names>R</given-names></name><name><surname>Ahonen</surname><given-names>J</given-names></name><name><surname>Tallgren</surname><given-names>M</given-names></name><name><surname>Haanp&#x000e4;&#x000e4;</surname><given-names>M</given-names></name><name><surname>Korttila</surname><given-names>K</given-names></name></person-group><article-title>A randomized controlled trial of perioperative administration of pregabalin for pain after laparoscopic hysterectomy</article-title><source>Pain</source><year>2008</year><volume>134</volume><fpage>106</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">17507163</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiippana</surname><given-names>EM</given-names></name><name><surname>Hamunen</surname><given-names>K</given-names></name><name><surname>Kontinen</surname><given-names>VK</given-names></name><name><surname>Kalso</surname><given-names>E</given-names></name></person-group><article-title>Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety</article-title><source>AnesthAnalg</source><year>2007</year><volume>104</volume><fpage>1545</fpage><lpage>56</lpage></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathiesen</surname><given-names>O</given-names></name><name><surname>Jacobsen</surname><given-names>LS</given-names></name><name><surname>Holm</surname><given-names>HE</given-names></name><name><surname>Randall</surname><given-names>S</given-names></name><name><surname>Adamiec-Malmstroem</surname><given-names>L</given-names></name><name><surname>Graungaard</surname><given-names>BK</given-names></name><etal/></person-group><article-title>Pregabalin and dexamethasone for postoperative pain control: A randomized controlled study in hip arthroplasty</article-title><source>Br J Anaesth</source><year>2008</year><volume>101</volume><fpage>535</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">18653493</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ittichaikulthol</surname><given-names>W</given-names></name><name><surname>Virankabutra</surname><given-names>T</given-names></name><name><surname>Kunopart</surname><given-names>M</given-names></name><name><surname>Khamhom</surname><given-names>W</given-names></name><name><surname>Putarawuthichai</surname><given-names>P</given-names></name><name><surname>Rungphet</surname><given-names>S</given-names></name></person-group><article-title>Effects of pregabalin on post operative morphine consumption and pain after abdominal hysterectomy with/without salphingo-oophorectomy: A randomized, double-blind trial</article-title><source>J Med Assoc Thai</source><year>2009</year><volume>92</volume><fpage>1318</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">19845240</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filos</surname><given-names>KS</given-names></name><name><surname>Patroni</surname><given-names>O</given-names></name><name><surname>Goudas</surname><given-names>LC</given-names></name><name><surname>Bosas</surname><given-names>O</given-names></name><name><surname>Kassaras</surname><given-names>A</given-names></name><name><surname>Gartaganis</surname><given-names>S</given-names></name></person-group><article-title>A dose-response study of orally administered clonidine as premedication in the elderly: Evaluating hemodynamic safety</article-title><source>AnesthAnalg</source><year>1993</year><volume>77</volume><fpage>1185</fpage><lpage>92</lpage></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>PF</given-names></name><name><surname>Tufanogullari</surname><given-names>B</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><name><surname>Klein</surname><given-names>K</given-names></name></person-group><article-title>The effect of pregabalin on preoperative anxiety and sedation levels: A dose-ranging study</article-title><source>AnesthAnalg</source><year>2009</year><volume>108</volume><fpage>1140</fpage><lpage>5</lpage></element-citation></ref></ref-list></back></article>